Document Detail

Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
MedLine Citation:
PMID:  2405089     Owner:  NLM     Status:  MEDLINE    
In a double-blind, randomized, cross-over study with a single-blind placebo run-in period a new controlled-release (CR) formulation of metoprolol 200 mg once daily was compared with atenolol tablets 100 mg once daily in 22 patients (age 60.9 +/- 0.93 (SE) years) with primary hypertension and impaired or diabetic glucose tolerance. Each period lasted for three weeks. The two agents produced similar blood pressure 3 h as well as 24 h after drug intake. Three hours after drug intake, heart rate was lower on atenolol than metoprolol CR treatment, indicating a higher degree of beta-receptor blockade for atenolol at this point in time, when the plasma concentration of atenolol was most likely to be close to its peak. Concentrations of blood glucose, serum insulin, and serum C-peptide in the fasting state or after an oral glucose load did not differ between the active agents. HbA1c was marginally, but significantly, lower on atenolol than metoprolol CR treatment. No differences were found in serum levels of total, low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol or apoA-I, and apoB lipoproteins or triglycerides. In comparison to the placebo run-in period, both agents showed an unexpected improvement in glucose tolerance, a decrease in HDL cholesterol and for metoprolol CR a small, but significant decrease in LDL cholesterol. Thus, treatment with metoprolol CR tablets producing even plasma levels without high peak concentrations and conventional atenolol treatment had similar effects on metabolic control in hypertensive men and abnormal glucose tolerance.
B Fagerberg; A Berglund; E Holme; L Wilhelmsen; D Elmfeldt
Related Documents :
7091159 - Cholesterol reduction by a high-glucose diet in a patient with homozygous familial hype...
11996949 - Pravastatin sodium, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, de...
9184709 - The use of alternate-day lovastatin in hypercholesterolemic men.
3605049 - Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular ri...
25344379 - Effect of acarbose on postprandial blood glucose concentrations in healthy cats fed low...
224699 - The association of total cholesterol, triglycerides and plasma lipoprotein cholesterol ...
8198489 - Cholesterol levels in general practice.
15616799 - Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-...
8844719 - Effects of fostering on the increased tumor incidence produced by a maternal diet high ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of internal medicine     Volume:  227     ISSN:  0954-6820     ISO Abbreviation:  J. Intern. Med.     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-03-07     Completed Date:  1990-03-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8904841     Medline TA:  J Intern Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  37-43     Citation Subset:  IM    
Department of Medicine, Gottenburg University, Sahlgrenska Hospital, Göteborg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atenolol / administration & dosage
Blood Pressure
C-Peptide / blood
Delayed-Action Preparations
Double-Blind Method
Glucose / metabolism*
Heart Rate
Hemoglobin A, Glycosylated / analysis
Hypertension / blood,  drug therapy*,  metabolism
Insulin / blood
Lipoproteins / metabolism*
Metoprolol / administration & dosage*
Middle Aged
Reg. No./Substance:
0/C-Peptide; 0/Delayed-Action Preparations; 0/Hemoglobin A, Glycosylated; 0/Lipoproteins; 11061-68-0/Insulin; 29122-68-7/Atenolol; 37350-58-6/Metoprolol; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Metabolic responses to euglycaemic hyperinsulinaemia in lactating and non-lactating sheep in vivo.
Next Document:  The effect of captopril and metoprolol as monotherapy or combined with bendroflumethiazide on blood ...